240 related articles for article (PubMed ID: 2015114)
1. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
Clements GJ; Price-Jones MJ; Stephens PE; Sutton C; Schulz TF; Clapham PR; McKeating JA; McClure MO; Thomson S; Marsh M
AIDS Res Hum Retroviruses; 1991 Jan; 7(1):3-16. PubMed ID: 2015114
[TBL] [Abstract][Full Text] [Related]
2. Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage.
Schulz TF; Reeves JD; Hoad JG; Tailor C; Stephens P; Clements G; Ortlepp S; Page KA; Moore JP; Weiss RA
AIDS Res Hum Retroviruses; 1993 Feb; 9(2):159-66. PubMed ID: 8457383
[TBL] [Abstract][Full Text] [Related]
3. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.
Niwa Y; Yano M; Futaki S; Okumura Y; Kido H
Eur J Biochem; 1996 Apr; 237(1):64-70. PubMed ID: 8620895
[TBL] [Abstract][Full Text] [Related]
4. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
[TBL] [Abstract][Full Text] [Related]
5. Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus.
Kido H; Niwa Y; Beppu Y; Towatari T
Adv Enzyme Regul; 1996; 36():325-47. PubMed ID: 8869754
[TBL] [Abstract][Full Text] [Related]
6. CD4 activation of HIV fusion.
Sattentau QJ
Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
[TBL] [Abstract][Full Text] [Related]
7. Thrombin activates envelope glycoproteins of HIV type 1 and enhances fusion.
Ling H; Xiao P; Usami O; Hattori T
Microbes Infect; 2004 Apr; 6(5):414-20. PubMed ID: 15109955
[TBL] [Abstract][Full Text] [Related]
8. Alanine substitution of two arginines in amino terminus of V3 of SIV disrupts CD4 binding whereas a similar replacement of two amino acids, lysine and arginine, in the carboxyl half of V3 prevents binding of a neutralizing monoclonal antibody.
Javaherian K; Zuchowski L; Clark FT
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1101-5. PubMed ID: 8554907
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of U-937 membrane-associated cathepsin G by GP120 (IIIB) and V3 loop-derived peptides from several strains of HIV-1.
Avril LE; di Martino-Ferrer M; Brillard-Bourdet M; Gauthier F
FEBS Lett; 1995 Jul; 367(3):251-6. PubMed ID: 7607317
[TBL] [Abstract][Full Text] [Related]
10. Changes in the reactivity and neutralizing activity of a type-specific neutralizing monoclonal antibody induced by interaction of soluble CD4 with gp120.
Maeda Y; Matsushita S; Hattori T; Murakami T; Takatsuki K
AIDS Res Hum Retroviruses; 1992 Dec; 8(12):2049-54. PubMed ID: 1493053
[TBL] [Abstract][Full Text] [Related]
11. Studies on the role of the V3 loop in human immunodeficiency virus type 1 envelope glycoprotein function.
Chiou SH; Freed EO; Panganiban AT; Kenealy WR
AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1611-8. PubMed ID: 1457207
[TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition of HIV-1 by CD4 binding domain reagents and V3-directed monoclonal antibodies.
Potts BJ; Field KG; Wu Y; Posner M; Cavacini L; White-Scharf M
Virology; 1993 Nov; 197(1):415-9. PubMed ID: 8212576
[TBL] [Abstract][Full Text] [Related]
13. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4.
Weinberg J; Liao HX; Torres JV; Matthews TJ; Robinson J; Haynes BF
AIDS Res Hum Retroviruses; 1997 May; 13(8):657-64. PubMed ID: 9168234
[TBL] [Abstract][Full Text] [Related]
14. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
15. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.
McCaffrey RA; Saunders C; Hensel M; Stamatatos L
J Virol; 2004 Apr; 78(7):3279-95. PubMed ID: 15016849
[TBL] [Abstract][Full Text] [Related]
16. An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization.
Back NK; Smit L; De Jong JJ; Keulen W; Schutten M; Goudsmit J; Tersmette M
Virology; 1994 Mar; 199(2):431-8. PubMed ID: 8122371
[TBL] [Abstract][Full Text] [Related]
17. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG
J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
[TBL] [Abstract][Full Text] [Related]
19. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
20. Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120.
McKeating JA; Shotton C; Cordell J; Graham S; Balfe P; Sullivan N; Charles M; Page M; Bolmstedt A; Olofsson S
J Virol; 1993 Aug; 67(8):4932-44. PubMed ID: 7687306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
